Cubist Systematic Strategies’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$790K Buy
+27,876
New +$755K ﹤0.01% 2055
2023
Q1
Sell
-44,364
Closed -$1.31M 4506
2022
Q4
$1.31M Sell
44,364
-54,169
-55% -$1.74M 0.01% 2206
2022
Q3
$3.84M Buy
98,533
+82,147
+501% +$3.76M 0.02% 1333
2022
Q2
$632K Buy
16,386
+10,920
+200% +$415K ﹤0.01% 2866
2022
Q1
$265K Sell
5,466
-2,043
-27% -$105K ﹤0.01% 2907
2021
Q4
$552K Buy
+7,509
New +$617K 0.01% 2370
2021
Q3
Sell
-3,809
Closed -$239K 3214
2021
Q2
$239K Buy
+3,809
New +$141K ﹤0.01% 2454
2020
Q1
Sell
-12,847
Closed -$237K 2505
2019
Q4
$237K Buy
+12,847
New +$213K ﹤0.01% 1967

Other funds holding ASTH

Cubist Systematic Strategies's ASTH Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Astrana Health (ASTH) in Q3 2025: 27,876 shares worth $790K. The stake represents ﹤0.01% of the portfolio and ranks #2055 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in ASTH as recently as Q4 2022.

Cubist Systematic Strategies first reported a position in ASTH in Q4 2019 and has held it in 8 quarters since. The position peaked at $3.84M in Q3 2022. 188 funds tracked by Wall St. Rank hold ASTH as of Q3 2025.

  • Cubist Systematic Strategies held 27,876 shares of Astrana Health worth $790K as of Q3 2025.
  • Astrana Health was a new Cubist Systematic Strategies position in Q3 2025.
  • Astrana Health made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2055 holding.
  • Cubist Systematic Strategies first reported a position in Astrana Health in Q4 2019 and has held it in 8 quarters since.
  • Cubist Systematic Strategies's Astrana Health position peaked at $3.84M in Q3 2022.
  • 188 funds tracked by Wall St. Rank held Astrana Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.